By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Vertex Pharmaceuticals Incorporated 

Research & Development
11010 Torreyana Road
San Diego  California  92121  U.S.A.
Phone: 858-404-6600 Fax: 858-404-6726


Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, cystic fibrosis, inflammation, autoimmune diseases, cancer, and pain.

Vertex Pharmaceuticals is an Equal Opportunity Employer.

Key Contacts
Patient Inquiries:

This div will be replaced

Key Statistics

Ownership: Public

Web Site: Vertex (CA)
Symbol: VRTX

Company News
Fading Vertex Pharmaceuticals (CA) (VRTX) Drug Incivek was Also Fastest to Become a Blockbuster 11/1/2013 8:12:31 AM
GlobalDataWith the Threat of Competition Looming, Vertex Pharmaceuticals (MA) (VRTX) Boasts of Promising New HCV Therapy 8/2/2012 11:26:49 AM
Vertex Pharmaceuticals (CA) (VRTX): Phase 3 STRIVE Study of VX-770 Showed Durable Improvements in Lung Function (FEV1) and Other Measures of Disease Among People With a Specific Type of Cystic Fibrosis 6/10/2011 11:00:26 AM
Vertex Pharmaceuticals (CA) (VRTX) Plans to Provide Access to Potential CF Therapy VX-770 for Patients with Critical Medical Need 6/10/2011 10:28:22 AM
Vertex Pharmaceuticals (CA) (VRTX) Announces Webcasts of its Presentations at Two Investor Conferences 5/27/2011 11:09:32 AM
Vertex Pharmaceuticals (CA) (VRTX) Announces Webcasts of its Presentations at Two Investor Conferences 5/2/2011 9:13:31 AM
Vertex Pharmaceuticals (CA) (VRTX) Stock Trading Halted Amid FDA Review 4/28/2011 7:09:51 AM
Vertex Pharmaceuticals (CA) (VRTX) Rises After FDA Staff Says Hepatitis C Drug Is Effective 4/26/2011 11:32:29 AM
Vertex Pharmaceuticals (CA) (VRTX) Announces the Date of its Full Year 2010 Financial Results Conference Call and Webcast 1/24/2011 8:10:33 AM
Vertex Pharmaceuticals (CA) (VRTX) Announces Key Business Objectives To Support Planned Launch of Telaprevir in Hepatitis C and Continued Progress in Other Serious Diseases 1/10/2011 11:41:57 AM